Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Paola Pedone
Maria Paola Pedone
Medicine
Intensive care medicine
Dupilumab
Ofatumumab
Immunology
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia
2020
Global & Regional Health Technology Assessment
Antonio Costanzo
Gianluca Furneri
Rossella Bitonti
Maria Paola Pedone
Francesca Fanelli
Roberta Di Turi
Show All
Source
Cite
Save
Citations (0)
The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service
2020
Global & Regional Health Technology Assessment
Claudio Jommi
Filippo Cipriani
Francesca Fanelli
Maria Paola Pedone
Walter Canonica
Show All
Source
Cite
Save
Citations (0)
Atopic dermatitis in schoolchildren and adolescents: a critical review of Italian epidemiological data and systemic treatments.
2020
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia
May El Hachem
Luigi Naldi
Iria Neri
Maria Paola Pedone
Francesca Fanelli
Carlotta Galeone
Show All
Source
Cite
Save
Citations (0)
Is Idelalisib Cost-Effective for Refractory/Relapsed Chronic Lymphocytic Leukemia? a Decision Analysis in the Second-Line Setting
2015
Blood
Monia Marchetti
Antonio Cuneo
Francesca Romana Mauro
Marco Montillo
Elisa Martelli
Maria Paola Pedone
Show All
Source
Cite
Save
Citations (1)
Prophylaxis with rivaroxaban against venous thromboembolism (VTE): a cost-consequence analysis from the Italian Healthcare Service perspective
2008
Cristina Negrini
Alex Diamantopoulos
Fiona Forster
Stefania Lopatriello
Michael Lees
Cosetta Bianchi
Maria Paola Pedone
Show All
Source
Cite
Save
Citations (0)
1